Science Policy Advocacy Strategies

California has built the largest aggregation of residential batteries in the world — over 720 megawatts enrolled in its Demand Side Grid Support program. What California hasn't done is make that capacity routine. DSGS and the Emergency Load Reduction Program activate only when CAISO declares a grid stress event, meaning the enrolled fleet its mandated for all new solar customers but not integrated into the way that California Utilities operate their grid. I get it, CAISO is one of the most complex wholesale markets in the world. But the fragmented result — NEM 3.0, DSGS, ELRP, and Rate tariff arbitrage running in parallel with different enrollment requirements — is the point. California built programs to satisfy policy mandates and forgot to integrate these resources to help acheive speed to power for data centers and load growth. Rocky Mountain Power's Wattsmart in Utah represents the opposite philosophy. Built as a direct operational tool from day one, the program ran more than 130 response events in 2024 — not emergencies, but routine grid balancing. The DOE called it among the most advanced VPPs in the country for its integration into system operations. Batteries dispatch in under 250 milliseconds, enabling frequency regulation that California's programs don't attempt. That control is what makes the resource reliable enough to count in capacity planning. ConnectedSolutions in the Northeast sits ahead of California on reliability. Its pay-for-performance model — locking incentive rates for five years, paying based on actual energy delivered — has 95–99% event response rates. Narrower in scope than Wattsmart, operating only in summer, but what it does it does consistently. Texas is the most structurally ambitious experiment. ERCOT's Aggregated Distributed Energy Resource pilot — born from the trauma of Winter Storm Uri — aims to let distributed batteries participate directly in wholesale energy and ancillary services markets, not just demand response. Now in Phase 3, the program has doubled its capacity cap to 160 megawatts and expanded into contingency reserve services. Seven commercial ADERs were participating as of late 2025, small in scale but sophisticated in architecture. Texas is attempting to give a home battery the same market standing as a conventional power plant. Importantly, sophisticated business models are already unlocked for home batteries through the wholesale market. The pattern is consistent: operational integration requires either a vertically integrated utility with direct dispatch authority, like Rocky Mountain Power, or a wholesale market genuinely built for small resources, like ERCOT is constructing. California has neither cleanly. The gap between its enrolled megawatts and its operational reliability is frustrating for those of us who think that California should lead on distributed energy.

🔴 Abu Dhabi Launches Solar Energy Self-Supply Policy 🇦🇪☀️ Abu Dhabi has introduced a Solar Energy Self-Supply Policy, enabling farms, ranches, and rest houses to generate and consume electricity on-site with optional battery storage for evening and peak demand use. This is not just renewable adoption. It is distributed energy engineering at sector level. ⚡ What the Policy Enables • On-site solar PV generation • Self-consumption without grid export (initial phase) • Optional battery storage integration • Licensed installation under regulated technical standards The phased rollout focuses primarily on agricultural and rural sectors, where land availability and daytime load profiles align naturally with solar generation. 🔎 Engineering & Grid Implications From a systems perspective, this initiative supports: • Decentralized generation architecture • Reduced peak grid strain • Enhanced local load balancing • Long-term infrastructure resilience • Smart demand-side energy management While immediate financial savings are not guaranteed, the policy prioritizes: • Grid stability over subsidy-driven adoption • Controlled technical compliance • Structured renewable integration • Sustainable electrification planning With electricity demand rising due to: • Population growth • AI-driven data infrastructure • Increased electrification across sectors Distributed solar becomes a strategic load management tool, not just a sustainability measure. Abu Dhabi is moving toward an energy model where consumption and generation increasingly coexist at the same location. This is energy independence engineered within a regulated framework. 👉 If decentralized solar expands beyond rural sectors, how might it reshape utility business models and long-term grid planning? #AbuDhabi #SolarEnergy #Renewables #EnergyInfrastructure #SmartGrid #SustainableDevelopment #DistributedEnergy #FutureEnergy #InfrastructureStrategy

🔌 Grid operators are implementing various strategies to manage the declining inertia caused by the increased penetration of variable generation (VG) resources, such as wind and solar. These strategies fall into three main categories: maintaining inertia, providing more response time, and enhancing fast frequency response. To maintain inertia, operators can ensure that a mix of synchronous generators is online to exceed critical inertia levels. Additionally, synchronous renewable energy sources and synchronous condensers can be deployed to provide inertia. To provide more response time, operators can reduce contingency sizes and adjust underfrequency load shedding (UFLS) settings. Finally, enhancing fast frequency response involves leveraging load resources, extracting wind kinetic energy, and dispatching inverter-based resources to improve the grid's ability to respond to frequency changes. 🍃 Extracted wind kinetic energy refers to the capability of wind turbines to provide fast frequency response (FFR) by utilising the kinetic energy stored in their rotating blades. This approach can be particularly effective in addressing the challenges posed by declining inertia in power systems with high wind penetration. By extracting kinetic energy, wind turbines can respond rapidly to frequency deviations, thereby helping to stabilise the grid. This method can be used in conjunction with other resources to enhance overall system reliability and maintain frequency within acceptable limits. 💡 High deployment of variable generation (VG) resources can be effectively managed by combining extracted kinetic energy from wind turbines and increasing output from curtailed wind plants. The figure below illustrates that when these two strategies are combined, they significantly mitigate frequency decline. The simulation shows that relying solely on extracted kinetic energy results in frequency falling below UFLS (underfrequency load shedding), while using only FFR barely avoids UFLS. However, when both methods are applied together, the frequency decline is minimal, demonstrating that these approaches can serve as viable alternatives to traditional inertia and primary frequency response from conventional generators. #gridmodernization #stability #gridforming #powerelectronics #renewables #cleanenergy #solidstate

FSSAI Introduces New Scientific Evidence Rule (Effective 1 Jan 2026) A turning point for food regulation in India India’s food regulatory framework is moving decisively from assumption-based safety to evidence-based decision making. From 1 January 2026, FSSAI will require robust scientific data for: Approval of new food products ➡️ Safety reviews of ingredients & formulations ➡️Revisions in existing food standards ➡️Risk assessments and exposure evaluations 🚫 “Trust us” claims are no longer acceptable Data will be the new currency of approval 🔬 What Scientific Evidence Will Be Required? Food businesses must submit standardised scientific dossiers, typically covering: 1️⃣ Nutritional Composition Macro & micro-nutrient profile Variability across batches Comparison with existing permitted foods 2️⃣ Intended Consumption Data Target population (adult / child / special groups) Serving size & frequency Cumulative exposure from multiple food sources 👉 This is critical to avoid over-exposure risks. 3️⃣ Toxicological Evidence NOAEL data Acute & chronic toxicity studies Margin of Safety (MoS) calculations 4️⃣ Allergen Risk Assessment Presence of known allergens Cross-contact risks Scientific justification for allergen labelling or exemptions 5️⃣ Safety Evidence from Studies Published peer-reviewed research In-house or third-party study reports International regulatory references (if scientifically justified) 🎯 Why This Rule Is a Big Deal ✔️ Moves India toward science-based regulation, not perception-based ✔️ Decisions aligned with Indian dietary patterns & exposure levels ✔️ Reduces ambiguity in approvals & objections ✔️ Builds long-term consumer trust in food safety This mirrors global regulatory thinking — but customized for Indian food habits, not blindly copied. 👩🔬 Impact on Food Businesses & Professionals Higher demand for: Food analysts Toxicology experts Accredited laboratories Regulatory & compliance consultants #FSSAI #FoodSafety #ScientificEvidence #FoodRegulation #RiskAssessment #FoodIndustryIndia #Compliance #QualityAssurance #FoodInnovation

🇬🇧 The UK just changed the way Real-World Evidence enters regulation. Quietly. Strategically. Powerfully. The MHRA has officially launched its Real-World Evidence (RWE) Scientific Dialogue Programme — and this is far more than another consultation route. It is a structural shift in how regulators and industry now engage on real-world data before it is used in submissions. For the first time at this scale, companies can enter early, confidential scientific dialogue with the regulator specifically on RWE design, data fitness, and analytical strategy, not as an afterthought but as a planned development pillar. This matters deeply. For years, RWE has lived in a grey zone: 🔹 Used to support access… 🔹 Used post-approval… 🔹 Often questioned for regulatory robustness… Now, the MHRA is effectively saying: 👉 “Bring your RWE to us early — let’s shape it together.” This signals three major shifts: 1️⃣ RWE is now moving upstream in drug development No longer just supportive or confirmatory — it is being positioned as a strategic design component. 2️⃣ Methodological credibility becomes a competitive advantage Study design, bias control, data linkage, fitness-for-purpose — these are no longer technical details. They are regulatory differentiators. 3️⃣ UK positions itself as a global RWE innovation sandbox With ILAP, the RWE Dialogue Programme, and post-Brexit agility, the UK is shaping a new evidence-generation ecosystem that blends trials and real-world practice. For leaders in: 🔹 RWE & Data Science 🔹 HEOR and Market Access 🔹 Regulatory Strategy 🔹 Clinical Development The message is clear: 🔹 RWE can no longer be improvised late in the lifecycle 🔹 Governance, design, and regulatory alignment must start Day 1 🔹 Organisations without a coherent RWE strategy will fall behind — fast 📢 RWE is no longer the “real-world add-on”. It is becoming part of the real regulatory core. #RWE #MHRA #RegulatoryScience #ClinicalDevelopment #HealthEconomics #MarketAccess #LifeSciences #PharmaLeadership #DataStrategy ⚖️ Disclaimer: Views expressed here are my own. Helios Academy Ltd — “Where Science Meets Compassion” — is an independent educational and coaching initiative (not yet trading). This post does not represent the views of Astellas Pharma, my employer, and contains no confidential or company-related information.

The FDA has released an important new draft guidance "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products" for public comment (link below) — a document that could shape how innovative medicines are developed for years to come. Among the notable advancements are (produced by Vivpro Corp's Regulatory Intelligence Assistant): • Recognizing upfront a single, highly persuasive clinical trial with confirmatory evidence may be sufficient. 💡 • A more holistic assessment of evidence, considering not only study design, but also trial conduct, analysis, generalizability, and integration across the development program. Recognizing Bayesian analysis as an acceptable approach is a welcome change. • Expanded regulatory flexibility, including greater consideration of real-world data, natural history studies, and mechanistic evidence 💡 where appropriate. Public comment periods are more than a regulatory process—they are an opportunity for the scientific community to help shape the future of regulatory science. One area that deserves inclusion is the role of Model-Integrated Evidence (MIE) (Quantitative Medicine). Over the past two decades, MIE has demonstrated its value in strengthening evidence of effectiveness without compromising scientific rigor. In my experience, this is THE most consequential Guidance to Quantitative Medicine groups. Whether you are in academia, industry, government, or clinical research, your experience and scientific perspective matter. Constructive, evidence-based comments can help ensure that future guidance reflects the full spectrum of modern drug development science. This public comment period provides an important opportunity to ensure that proven quantitative approaches are fully considered in the next generation of regulatory guidance—ultimately supporting more efficient drug development and faster access to effective therapies for patients. I encourage colleagues across the scientific community to review the draft guidance and consider submitting comments to the FDA docket. Thoughtful voices today will help shape tomorrow's standards. Center for Translational Medicine UMB https://lnkd.in/eBJ5k7qA

Just read this excellent new paper by Guy Pe'er and colleagues on the role of science and scientists in EU environmental policymaking, focusing on the Nature Restoration Regulation (NRR) and the Sustainable Use Regulation (SUR). As someone active at the science-policy interface of the EU #GreenDeal, it resonates strongly. The paper dissects how misinformation and short-term political pressures derailed the SUR, while sustained scientific engagement helped secure the NRR. It provides a sharp analysis of claims used against these regulations — on food security, yields, jobs, and energy — and contrasts them with robust scientific evidence. What stands out is the authors’ call for scientists to be proactive, credible, and collaborative in the public arena, especially when evidence is distorted or ignored. The open letter by 6,000 scientists in support of the NRR shows that collective scientific voice can matter. This is more than a case study. It’s a reminder that evidence-based policy needs evidence-based politics, and scientists willing to speak up. (Of course, “evidence-based” doesn’t mean all scientists will always agree. But on many issues, like the urgency of biodiversity restoration or the risks of pesticide overuse, there is strong consensus that deserves more serious political attention. At the very least, democratic politics should take better stock of the best available science.) Highly recommended reading for anyone working on sustainability, #foodsystems, or environmental governance. https://lnkd.in/eB_BeYxs

Do current EU structures for Regulatory Science maximise the contribution the academic sectors can make? Are there lessons to learn from the US, and recently the UK CERSI model. What are CERSIs, ... I (pretend to) hear you ask ...? Centres of Excellence in Regulatory Science and Innovation. We address the important role of CERSI's in our paper “European Union innovation needs regulatory science excellence centres” published this week in Nature Portfolio Nature Biomedical Engineering. Anett Schönfelder, together with an international group of experts — Alastair Denniston, Prof Alejandro Frangi FREng, Prof. Dr. Christian Johner, Timo Minssen, Kuldev Singh and Stephen Gilbert — argue for a model that could help Europe rethink how regulation evolves alongside innovation: The model has already demonstrated its value in the US and was recently established in the UK. CERSIs bring regulators, academia and industry together in an independent, collaborative co-learning structure. They can help identify regulatory gaps and emerging trends, develop tools and evaluation methods, and provide scientific consultation and education. Read the full article here 👉🏼https://rdcu.be/fwDd2 Else Kröner Fresenius Center for Digital Health TUD | Faculty of Medicine #RegulatoryScience #DigitalHealth #Innovation

#MDR and #IVDR poses challenges for innovators, especially #SMEs. This paper, co-authored with Bianca Cavicchi, Hanna Vuorinen and the expert Stephen Gilbert, examines how EU Research and Innovation policy can complement regulatory frameworks to make them more innovation-friendly in the field of #MedicalDevices and #inVitroDiagnositcs. 3 main takeaways: ⚖️ 🏖️Regulatory #sandboxes: MDR/IVDR need to include a legal basis for time-bound adaptation/waivers of MDR/IVDR rules to test in real-world conditions outstanding innovations covering unmet medical needs. The Innovative Health Initiative (IHI) project BRIDGE comes at the perfect time to provide guidance on regulatory sandboxes for MD/IVD. 🌅 📞 Early dialogue: manufacturers need support from regulators early on in the R&D process of new devices. This already happens for medicines, with great success, thanks to European Medicines Agency expert advice. ⚖️ 🔬 Regulatory science initiatives: to future-proof MDR/IVDR (and in general, tech-focused regulations...) we need structured dialogues with the scientific community feeding into regulatory processes directly. A model we like is that of CERSIs, successful in both UK and USA. Thanks to the many stakeholders who contributed with their expert opinions to the study. Big thanks to Stephen in particular for the heavy-lifting and to Bianca for her leadership and coordination. https://lnkd.in/ejqf5WmM